Estimating antiviral effectiveness against pandemic influenza using household data (Q30373782)

13 September 2017

Estimating antiviral effectiveness against pandemic influenza using household data (English)

1 reference

13 September 2017

0 references

Kathryn Glass

1

1 reference

PMC publication ID

2839940

13 September 2017

Niels G Becker

series ordinal

2

1 reference

13 September 2017

5 December 2008

1 reference

Journal of the Royal Society Interface

13 September 2017

1 reference

13 September 2017

6

1 reference

13 September 2017

37

1 reference

13 September 2017

695-703

1 reference

The role of health care workers and antiviral drugs in the control of pandemic influenza.

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Antivirals in the management of an influenza pandemic.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Antivirals for influenza in healthy adults: systematic review.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Strategies for containing an emerging influenza pandemic in Southeast Asia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Containing pandemic influenza at the source.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Feds to stockpile antivirals as pandemic "speed bump".

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1098%2FRSIF.2008.0404

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1098%2FRSIF.2008.0404

Influenza as an issue on the agenda of policy makers and government representatives. What can we do? What do we need?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839940

Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19064345

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1098/RSIF.2008.0404

1 reference

13 September 2017

1 reference

PMC publication ID

2839940

13 September 2017

PubMed publication ID

19064345

1 reference

PMC publication ID

2839940